KRYS Krystal Biotech, Inc.
Healthcare$302.68+1.08%ClosedMarket Cap: $8.92B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$326.20
Target (Median)
$323.00
Target Range
$300.00 - $371.00
Upside from current price: 7.8%
Rating Distribution
0 Strong Buy10 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-22 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-05 | Citigroup | maintain | Buy | Buy |
| 2026-05-05 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-02-25 | Guggenheim | maintain | Buy | Buy |
| 2026-02-18 | Chardan Capital | maintain | Buy | Buy |
| 2026-02-18 | Citigroup | maintain | Buy | Buy |
| 2026-02-17 | Jefferies | maintain | Buy | Buy |
| 2026-02-02 | Goldman Sachs | maintain | Buy | Buy |
| 2026-01-22 | B of A Securities | maintain | Buy | Buy |
| 2026-01-12 | Citigroup | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $9.71 | $659.6M | 7 |
| Sun Dec 31 | $12.76 | $847.9M | 5 |
| Mon Dec 31 | $25.19 | $1.33B | 1 |
| Tue Dec 31 | $34.84 | $1.73B | 1 |